{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:45:23Z","timestamp":1787071523731,"version":"build-2736575974"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Oral submucous fibrosis (OSF) is a chronic, progressive, and irreversible fibrotic disorder of the oral mucosa that is strongly associated with areca nut consumption. It is classified as an oral potentially malignant disorder (OPMD) with one of the highest malignant transformation rates (4%\u20137%). Despite extensive research across Asia and globally, significant heterogeneity persists in diagnostic criteria, grading systems, and management strategies. This hinders effective clinical practice, surveillance, and public health policymaking. By integrating translational evidence on areca nut\u2013associated fibrosis, oral potentially malignant disorders, and oral cancer into a consensus-driven framework, this manuscript advances biologically informed, equitable, and collaborative strategies for oral cancer prevention and early risk reclassification in resource-limited settings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This guideline was developed through a structured consensus process modelled on the ACCORD reporting framework for consensus-based biomedical research. A multi-institutional steering committee was convened, and included senior oral pathologists and clinicians: Vinay Hazarey (VH), WM Tilakaratne (WMT), Kannan Ranganathan (KR), Raghu Radhakrishnan (RR), Jayanta Chattopadhyay (JC), Punnya V Angadi (PA), Karishma Desai (KD), and Pratibha Ramani (PR) (as a moderator from Saveetha Dental College, Chennai). The panel head was Dinesh Daftary (DD). Evidence was synthesised from peer-reviewed publications indexed in PubMed, Scopus, and Web of Science. Consensus was defined as \u226580% agreement following structured rounds of discussion. The recommendations were graded as Strong or Conditional according to the quality of evidence, feasibility, and global applicability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The panel achieved a consensus on key areas: (1) OSMF is caused primarily by areca nut, a Group I carcinogen with no safe level of use; (2) clinical diagnosis should combine functional limitations with mucosal changes, supported by histopathology that incorporates fibrosis severity and epithelial dysplasia; (3) management should prioritize habit cessation, supplemented by pharmacological and surgical interventions as appropriate; (4) malignant transformation warrants long-term surveillance and potential revision of staging for OSMF-related oral cancer; and (5) strong public health measures are urgently needed, including regulation of areca nut sales and the establishment of centres of Excellence for OPMDs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>These WHO-style guidelines provide an evidence-based, globally relevant framework for the diagnosis, management, and prevention of OSMF. The emphasis should be on early detection, habit cessation, translational research, and policy reforms. The adoption of these recommendations will strengthen clinical practice and reduce the burden of OSMF, and associated oral cancer worldwide.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jomfp.jomfp_352_25","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T08:00:20Z","timestamp":1775116820000},"page":"2-13","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Global expert consensus on oral submucous fibrosis: Standardizing care, surveillance, and prevention strategies"],"prefix":"10.4103","volume":"30","author":[{"given":"Pratibha","family":"Ramani","sequence":"first","affiliation":[{"name":"Department of Oral and Maxillofacial Pathology, Saveetha Dental College and Hospitals, SIMATS, Chennai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinay K.","family":"Hazarey","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Pathology, Government Dental College and Hospital, Nagpur, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kannan","family":"Ranganathan","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Pathology, Ragas Dental College, Chennai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayanta","family":"Chattopadhyay","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Pathology, Kusumdevi Sunderlal Dugar Jain Dental College, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Punnya","family":"Angadi","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Pathology, KLE VK Institute of Dental Sciences, KAHER, Belagavi, Belagavi, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. M.","family":"Tilakarathne","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Clinical Sciences, Faculty of Dentistry, University of Malaya, Kuala, Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghu","family":"Radhakrishnan","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Pathology, Manipal College of Dental Sciences, Manipal, Karnataka, India; Industry and Community Engagement, Oman Dental College, Muscat, Oman"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karishma","family":"Desai","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Pathology, Tokyo Dental College, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh K.","family":"Daftary","sequence":"additional","affiliation":[{"name":"Department of Oral Pathology and Bacteriology, Nair Hospital Dental College, Tata Institute of Fundamental Research, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abilasha","family":"Ramasubramanian","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Pathology, Saveetha Dental College and Hospitals, SIMATS, Chennai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramya","family":"Ramadoss","sequence":"additional","affiliation":[{"name":"Department of Oral Biology, Saveetha Dental College and Hospitals, SIMATS, Chennai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Hema Shree","sequence":"additional","affiliation":[{"name":"Department of Oral Biology and Oral and Maxillofacial Pathology, Saveetha Dental College and Hospitals, SIMATS, Chennai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"key":"R1-20260420","first-page":"e49642","article-title":"Prevalence of oral submucous fibrosis with other oral potentially malignant disorders: A clinical retrospective study","volume":"15","author":"Sowmya","year":"2023","journal-title":"Cureus"},{"key":"R2-20260420","doi-asserted-by":"crossref","first-page":"e778","DOI":"10.4317\/medoral.24747","article-title":"High prevalence of oral potentially malignant disorders and risk factors in a semi-urban Brazilian city: A population-based cross-sectional study","volume":"26","author":"Martins-de-Barros","year":"2021","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"R3-20260420","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/13556210020091437","article-title":"Global epidemiology of areca nut usage","volume":"7","author":"Gupta","year":"2002","journal-title":"Addict Biol"},{"key":"R4-20260420","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1177\/1757913918785398","article-title":"Areca nut trade, globalisation and its health impact: Perspectives from India and South-east Asia","volume":"139","author":"Arora","year":"2019","journal-title":"Perspect Public Health"},{"key":"R5-20260420","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4103\/0974-8520.169018","article-title":"A pilot study on Ayurvedic management of oral submucous fibrosis","volume":"36","author":"Patel","year":"2015","journal-title":"Ayu"},{"key":"R6-20260420","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1177\/00220345221092751","article-title":"Areca nut and oral cancer: Evidence from studies conducted in humans","volume":"101","author":"Warnakulasuriya","year":"2022","journal-title":"J Dent Res"},{"key":"R7-20260420","doi-asserted-by":"crossref","first-page":"9967097","DOI":"10.1155\/2021\/9967097","article-title":"Areca nut chewing: Initiation, addiction, and harmful effects emphasizing the barriers and importance of cessation","volume":"2021","author":"Athukorala","year":"2021","journal-title":"J Addict"},{"key":"R8-20260420","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/S0194-59980300176-1","article-title":"Gene polymorphisms in detoxification enzymes as susceptibility factor for head and neck cancer?","volume":"128","author":"Gronau","year":"2003","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R9-20260420","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cca.2007.04.014","article-title":"The role of epithelial-mesenchymal transition in oral squamous cell carcinoma and oral submucous fibrosis","volume":"383","author":"Yanjia","year":"2007","journal-title":"Clin Chim Acta"},{"key":"R10-20260420","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40463-020-0399-7","article-title":"Oral submucous fibrosis: A contemporary narrative review with a proposed inter-professional approach for an early diagnosis and clinical management","volume":"49","author":"Rao","year":"2020","journal-title":"J Otolaryngol Head Neck Surg"},{"key":"R11-20260420","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1186\/s12967-025-07141-7","article-title":"Influence of healthy lifestyle on the incidence and survival of cancer and its comorbidities: Evidence from a longitudinal cohort study","volume":"23","author":"Cheng","year":"2025","journal-title":"J Transl Med"},{"key":"R12-20260420","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.bjoms.2012.08.014","article-title":"Oral submucous fibrosis: An overview of the aetiology, pathogenesis, classification, and principles of management","volume":"51","author":"Arakeri","year":"2013","journal-title":"Br J Oral Maxillofac Surg"},{"key":"R13-20260420","doi-asserted-by":"crossref","first-page":"11771","DOI":"10.3390\/ijms241411771","article-title":"Comparison of Immunohistochemical markers in oral submucous fibrosis and oral submucous fibrosis transformed to oral squamous cell carcinoma\u2014A systematic review and meta-analysis","volume":"24","author":"Mohapatra","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R14-20260420","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.3390\/ijms20122940","article-title":"Oral submucous fibrosis: A review on etiopathogenesis, diagnosis, and therapy","volume":"20","author":"Shih","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R15-20260420","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jclinepi.2014.10.011","article-title":"World Health Organization strong recommendations based on low-quality evidence (study quality) are frequent and often inconsistent with GRADE guidance","volume":"72","author":"Alexander","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"R16-20260420","doi-asserted-by":"crossref","first-page":"199","DOI":"10.4103\/0973-1482.98970","article-title":"Pathogenesis of oral submucous fibrosis","volume":"8","author":"Khan","year":"2012","journal-title":"J Cancer Res Ther"},{"key":"R17-20260420","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.oraloncology.2005.08.005","article-title":"Oral submucous fibrosis: Review on aetiology and pathogenesis","volume":"42","author":"Tilakaratne","year":"2006","journal-title":"Oral Oncol"},{"issue":"19","key":"R18-20260420","doi-asserted-by":"crossref","first-page":"7231","DOI":"10.3390\/ijms21197231","article-title":"Oral submucous fibrosis: A review on biomarkers, pathogenic mechanisms, and treatments","volume":"21","author":"Shen","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R19-20260420","first-page":"e78481","article-title":"Predictors of dysplasia in oral submucous fibrosis: A retrospective observational study","volume":"17","author":"Shete","year":"2025","journal-title":"Cureus"},{"key":"R20-20260420","doi-asserted-by":"crossref","first-page":"7530","DOI":"10.3390\/ijms25147530","article-title":"Natural compounds for preventing age-related diseases and cancers","volume":"25","author":"Ki","year":"2024","journal-title":"Int J Mol Sci"},{"key":"R21-20260420","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/02537176221144711","article-title":"A review of intervention strategies for areca nut use cessation","volume":"45","author":"Dhingra","year":"2023","journal-title":"Indian J Psychol Med"},{"key":"R22-20260420","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s12663-017-1041-8","article-title":"Collagen membrane over buccal fat pad versus buccal fat pad in management of oral submucous fibrosis: A comparative prospective study","volume":"17","author":"Singh","year":"2018","journal-title":"J Maxillofac Oral Surg"},{"key":"R23-20260420","doi-asserted-by":"crossref","first-page":"105832","DOI":"10.1016\/j.jdent.2025.105832","article-title":"Photobiomodulation for stem cell modulation and regenerative medicine-WALT position paper 2025","volume":"159","author":"Azarsina","year":"2025","journal-title":"J Dent"},{"key":"R24-20260420","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.3390\/jcm11071793","article-title":"Malignant transformation rate of oral submucous fibrosis: A systematic review and meta-analysis","volume":"11","author":"Murthy","year":"2022","journal-title":"J Clin Med"},{"key":"R25-20260420","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1186\/s12885-025-14415-2","article-title":"Correlation of clinical presentation with prognosis in oral squamous cell carcinoma associated with oral submucous fibrosis","volume":"25","author":"Alka","year":"2025","journal-title":"BMC Cancer"},{"key":"R26-20260420","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jobcr.2019.06.016","article-title":"Proposed clinical definition for oral submucous fibrosis","volume":"9","author":"More","year":"2019","journal-title":"J Oral Biol Craniofac Res"},{"key":"R27-20260420","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.3390\/jpm12081272","article-title":"Comparative efficacy of interventions for the management of oral submucous fibrosis: A systematic review and network meta-analysis","volume":"12","author":"Gopinath","year":"2022","journal-title":"J Pers Med"},{"key":"R28-20260420","doi-asserted-by":"crossref","first-page":"751","DOI":"10.6026\/973206300200751","article-title":"Prevalence of oral submucous fibrosis linking with Areca Nut usage among Indians","volume":"20","author":"Jayaswal","year":"2024","journal-title":"Bioinformation"},{"key":"R29-20260420","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3390\/clinpract13020030","article-title":"Carcinogenic effects of areca nut and its metabolites: A review of the experimental evidence","volume":"13","author":"Senevirathna","year":"2023","journal-title":"Clin Pract"},{"key":"R30-20260420","doi-asserted-by":"crossref","article-title":"The prevalence of comorbid mental health difficulties in young people with chronic skin conditions: A systematic review and meta-analysis","author":"Flinn","DOI":"10.1177\/13591053241252216"},{"key":"R31-20260420","doi-asserted-by":"crossref","first-page":"308","DOI":"10.4103\/jomfp.JOMFP_177_18","article-title":"Assessment of epithelial-mesenchymal transition signatures in oral submucous fibrosis","volume":"23","author":"Prasad","year":"2019","journal-title":"J Oral Maxillofac Pathol"},{"key":"R32-20260420","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4103\/jispcd.JISPCD_207_22","article-title":"Challenges in the classification of oral submucous fibrosis and proposing a new classification based on systematic review of literature","volume":"13","author":"Gupta","year":"2023","journal-title":"J Int Soc Prev Community Dent"},{"key":"R33-20260420","first-page":"56","article-title":"ERN GENTURIS tumour surveillance guidelines for individuals with neurofibromatosis type 1","author":"Carton","year":"2023","journal-title":"EClinicalMedicine"},{"key":"R34-20260420","doi-asserted-by":"crossref","first-page":"e12464","DOI":"10.1111\/jicd.12464","article-title":"Comparative evaluation of curcumin and antioxidants in the management of oral submucous fibrosis","volume":"10","author":"Rai","year":"2019","journal-title":"J Investig Clin Dent"},{"key":"R35-20260420","doi-asserted-by":"crossref","first-page":"102120","DOI":"10.1016\/j.jormas.2024.102120","article-title":"Molecular profiling of oral epithelial dysplasia and oral squamous cell carcinoma using next generation sequencing","volume":"126","author":"Krishnan","year":"2025","journal-title":"J Stomatol Oral Maxillofac Surg"},{"key":"R36-20260420","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.bjoms.2025.07.007","article-title":"Immunohistochemical evaluation of Ki67 in predicting malignant transformation in oral submucous fibrosis","volume":"63","author":"Kamala","year":"2025","journal-title":"Br J Oral Maxillofac Surg"},{"key":"R37-20260420","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jobcr.2025.06.006","article-title":"An in-vitro exploration of the antifibrotic activity of Naringenin: A potential therapeutic agent for oral submucous fibrosis management","volume":"15","author":"Samyuktha Aarthi","year":"2025","journal-title":"J Oral Biol Craniofac Res"}],"container-title":["Journal of Oral and Maxillofacial Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jomfp.jomfp_352_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:47:25Z","timestamp":1787068045000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jomfp.jomfp_352_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/jomfp.jomfp_352_25","relation":{},"ISSN":["0973-029X","1998-393X"],"issn-type":[{"value":"0973-029X","type":"print"},{"value":"1998-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"2025-11-13","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-12","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}